Request Demo
Recent blog posts
Latest Hotspot
8 min read
NCT07615751 Pyrotinib Maleate Advanced HER2-Positive Breast Carcinoma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
22 July 2026
NCT07615751 clinical trial report covering Pyrotinib Maleate, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07613450 SYHA-1813 Meningioma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
22 July 2026
NCT07613450 clinical trial report covering SYHA-1813, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07614776 Aflibercept-ayyh Wet age-related macular degeneration Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
22 July 2026
NCT07614776 clinical trial report covering Aflibercept-ayyh, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07612657 Tacrolimus Pulmonary Arterial Hypertension Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
22 July 2026
NCT07612657 clinical trial report covering Tacrolimus, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07613294 Lepodisiran sodium Atherosclerosis Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
22 July 2026
NCT07613294 clinical trial report covering Lepodisiran sodium, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07615101 68Ga-NYM032 Prostatic Cancer Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
22 July 2026
NCT07615101 clinical trial report covering 68Ga-NYM032, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07614152 Y-shape pegylated somatropin (Xiamen Amoytop Biotech) Dwarfism Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
22 July 2026
NCT07614152 clinical trial report covering Y-shape pegylated somatropin (Xiamen Amoytop Biotech), Phase 3, endpoints, sponsor, geography, readout timing and d
Latest Hotspot
8 min read
NCT07613307 Orforglipron Diabetes Mellitus, Type 2 Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
22 July 2026
NCT07613307 clinical trial report covering Orforglipron, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07613099 [18F]FAPI-74 Acute Lung Injury Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
22 July 2026
NCT07613099 clinical trial report covering [18F]FAPI-74, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07613528 Progesterone Pregnancy Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
22 July 2026
NCT07613528 clinical trial report covering Progesterone, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
CTR20262153 Fluorofenidone Hepatitis B, Chronic Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
22 July 2026
CTR20262153 clinical trial report covering Fluorofenidone, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
CTR20262075 Quadrivalent inactivated enterovirus vaccine(Sinovac Biotech) Hand, Foot and Mouth Disease Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
22 July 2026
CTR20262075 clinical trial report covering Quadrivalent inactivated enterovirus vaccine(Sinovac Biotech), Phase 3, endpoints, sponsor, geography, readout timi